Ethereum's Zora Platform Announces ZORA Token Release on April 23
Zora, an Ethereum-based platform recognized for its focus on non-fungible tokens (NFTs) and creator-centric content, has announced the launch of its native token, ZORA, set for April 23, 2025.
The announcement was made on April 21 through a post on X, detailing the token's distribution plan, which will utilize two snapshots of user activity.
The first snapshot will account for contributions made from Jan. 1, 2020, to March 3, 2025, while the second will include data up to April 20, 2025. This approach aims to identify eligible participants for a retroactive airdrop and reward long-time users, including creators, collectors, and developers within the Zora ecosystem.
ZORA will be launched on Base, the layer-2 network operated by Coinbase, rather than on Zora's own layer-2 solution. This decision is seen as a strategic move to enhance accessibility for new users, as Base has emerged as a prominent platform for on-chain social applications and meme coins.
The total supply of the ZORA token will be capped at 10 billion tokens. Of this, 10% is allocated for the airdrop, while another 20% is earmarked for future community incentives, such as grants and hackathons. Additionally, 5% of the supply will be used to provide liquidity.
The Zora treasury will receive 20% of the total supply, which will be gradually unlocked over four years following a six-month delay.
Team members are set to receive 18.9% of the tokens, with monthly vesting over three years, also subject to a six-month delay. The remaining 26.1% will be distributed to strategic contributors, including early investors and advisors.
Importantly, the ZORA token will not carry governance rights or equity claims, marking a significant step in Zora's evolution from an NFT platform to a comprehensive on-chain social network.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Post
19 minutes ago
- New York Post
Nintendo Switch 2 smashes record as company's fastest-selling console
Japan's Nintendo said on Wednesday it had sold more than 3.5 million Switch 2 units in the first four days after its launch, making the console the company's fastest-selling gaming device to date. Last month, the Kyoto-based company forecast Switch 2 sales would reach 15 million during the current financial year ending next March. 'Fans around the world are showing their enthusiasm for Nintendo Switch 2 as an upgraded way to play at home and on the go,' Nintendo of America President and Chief Operating Officer Doug Bowser said in a statement. Advertisement 3 A person wearing a Luigi hat sits in line playing a Nintendo Switch, waiting to buy a Nintendo Switch 2 in New York City on June 4, 2025. REUTERS 3 A person holds a stack of Nintendo Switch 2 devices while restocking at Nintendo's store in Rockefeller Center on June 5, 2025. AP 3 A man shows off the Nintendo Switch 2 inside a Tokyo store on June 5, 2025. AFP via Getty Images Advertisement Nintendo has sold 152 million Switch devices since it was first launched in 2017, creating a games juggernaut with titles including 'The Legend of Zelda' and COVID-19 pandemic breakout hit 'Animal Crossing: New Horizons.' The more powerful second-generation version, which went on sale on June 5, bears many similarities with its predecessor but offers a larger screen and improved graphics. It is sold with titles including 'Mario Kart World.'
Yahoo
23 minutes ago
- Yahoo
Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company
UPPSALA, SE / / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, has signed a new Master Service Agreement (MSA) - along with an initial Work Order of ~800 kSEK - with a Tier-1 US-based biopharmaceutical company. The new customer, a global leader in oncology drug development, becomes the fifth Tier-1 US biopharma company to join Biovica's Pharma Services customer base. The agreement covers testing of Phase 1 clinical trial samples in support of the development of next-generation CDK4/6 inhibitors and is a pilot study with DiviTum® TKa. " This marks a milestone in our growing customer base, highlighting the increasing relevance of Biovica's TKa biomarker assay in advanced cancer therapy development. It demonstrates the strong and growing recognition of the value our assay brings to the development of next-generation oncology treatments that ultimately benefit cancer patients. ," said Anders Rylander, CEO of Biovica. Contact Anders Rylander, CEOPhone: +46 76 666 16 47E-mail: Anders Morén, CFOPhone: +46 73 125 92 46E-mail: Biovica - Treatment decisions with greater confidence Biovica develops and commercializes blood-based biomarker assays that help oncologists monitor cancer progression. Biovica's assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker in the bloodstream. The assay has demonstrated its ability to provide insight to therapy effectiveness in several clinical trials. The first application for the DiviTum® TKa test is treatment monitoring of patients with metastatic breast cancer. Biovica's vision is: "Improved care for cancer patients." Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum® TKa has received FDA 510(k) clearance in the US and is CE-marked in the EU. Biovica's shares are traded on the Nasdaq First North Premier Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser. For more information, please visit: Attachments Biovica signs agreement with fifth Tier-1 US biopharma company SOURCE: Biovica International View the original press release on ACCESS Newswire Sign in to access your portfolio

Business Insider
24 minutes ago
- Business Insider
Qantas is pulling the plug on Jetstar Asia — and 500 jobs
Qantas is shutting down Jetstar Asia, its Singapore-based budget carrier, blaming rising operating costs and a crowded market. The budget airline will cease operations on July 31 after more than two decades. Jetstar Asia will continue flights until then on a "progressively reduced schedule," Qantas said in a statement on Wednesday. "Despite delivering exceptional customer service and operational reliability, Jetstar Asia has been impacted by rising supplier costs, high airport fees, and intensified competition in the region," the Australian company said. Jetstar Asia flies 16 routes from Singapore to destinations in Malaysia, Thailand, Indonesia, Japan, the Philippines, China, Sri Lanka, and Australia. Jetstar operations in Australia, New Zealand and Japan will not be affected. Customers booked on canceled flights will be offered full refunds, and Qantas will try to move them to other airlines where possible. The shutdown will also result in the loss of more than 500 jobs, a Jetstar Asia spokesperson told Business Insider. Affected employees will be given redundancy benefits and assistance with other roles within Qantas and other airlines. Qantas added that 13 Jetstar Asia Airbus A320 aircraft will be progressively redirected to Australia and New Zealand. Qantas did not immediately respond to a request for comment. Competition among budget carriers in Southeast Asia was "brutal," Alan Tan, a professor specializing in aviation law at the National University of Singapore's Law School, told Business Insider. "The departure is a great loss from the viewpoint of price and service competition for travellers," he said. Virgin Australia IPO The closure comes on the same day that Virgin Australia announced its intention to list on the stock market in Sydney on June 24. The shares will be priced at A$2.90, raising A$685 million and valuing the company at A$2.3 billion. The IPO will allow some existing investors, including Bain Capital, Qatar Airways Group, and the Virgin Group, to realize part of their holdings. Investors participating in the offer are expected to hold about 30% of shares on issue, with the remainder being held by existing investors. Virgin carries about 20 million passengers a year on more than 100 aircraft. It operates 76 routes to 38 destinations across its domestic and short-haul international airline business. From next week it will start long-haul international services between Australia and Doha in partnership with Qatar Airways, which has a 25% stake in Virgin. Budget model is 'dead' United Airlines CEO Scott Kirby earlier this month criticized the budget airline model and called it "crappy." He told the "Future of Everything" event that the low-cost carrier model was "dead." "The model was screw the customer," he said. "It was like trick people, get them to buy, and get them to come, and then charge them a whole bunch of fees that they aren't expecting … disclosures buried in legalese," he continued. "Their problem is they got big enough that they needed repeat customers. They don't get them." His comments came the same day that United announced a new partnership with JetBlue, which some consider to be a budget carrier.